This study, called the Inova Cardiogenic Shock Registry, is looking back at information from patients who have experienced cardiogenic shock (a serious condition where your heart can't pump enough blood to meet your body's needs). It's focused on patients treated by the Cardiogenic Shock Team at the Inova Heart and Vascular Institute. The goal is to understand how well current treatments work, compare survival rates before and after the team was formed, and see how different types of mechanical support (like ECMO or Impella) affect outcomes. You could be included if you are between 18 and 85 years old and received care from the Cardiogenic Shock Team for acute decompensated heart failure cardiogenic shock or acute myocardial infarction cardiogenic shock. The study aims to gather information from up to 3000 patients. The current status of the study is unclear.

Study design

This is an observational study, meaning researchers are collecting information from existing patient records rather than giving new treatments. It plans to include up to 3000 participants.

What's involved

Not specified in the trial record.

Compensation

Not stated in the trial record.

Follow-up

Patient outcomes will be reviewed for up to 1 year.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.